ISIN | LU1159236501 |
---|---|
Valor Number | 29080962 |
Bloomberg Global ID | |
Fund Name | State Street Europe Screened Index Equity Fund P |
Fund Provider |
State Street Global Advisors
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the Fund is to track the performance of the Eurozone equity markets. |
Peculiarities |
Current Price * | 18.17 EUR | 03.04.2025 |
---|---|---|
Previous Price * | 18.67 EUR | 02.04.2025 |
52 Week High * | 19.53 EUR | 03.03.2025 |
52 Week Low * | 16.97 EUR | 06.08.2024 |
NAV * | 18.17 EUR | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 693,975,093 | |
Unit/Share Assets *** | 34,414,085 | |
Trading Information SIX |
YTD Performance | +3.04% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
---|---|---|
YTD Performance (in CHF) | +4.01% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
1 month | -6.99% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 months | +2.97% |
03.01.2025 - 03.04.2025
03.01.2025 03.04.2025 |
6 months | +0.92% |
03.10.2024 - 03.04.2025
03.10.2024 03.04.2025 |
1 year | +4.23% |
03.04.2024 - 03.04.2025
03.04.2024 03.04.2025 |
2 years | +18.67% |
03.04.2023 - 03.04.2025
03.04.2023 03.04.2025 |
3 years | +20.84% |
04.04.2022 - 03.04.2025
04.04.2022 03.04.2025 |
5 years | +84.23% |
03.04.2020 - 03.04.2025
03.04.2020 03.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 2.66% | |
---|---|---|
SAP SE | 2.66% | |
ASML Holding NV | 2.55% | |
Nestle SA | 2.33% | |
AstraZeneca PLC | 2.19% | |
Roche Holding AG | 2.14% | |
Novartis AG Registered Shares | 1.95% | |
HSBC Holdings PLC | 1.93% | |
Shell PLC | 1.88% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.83% | |
Last data update | 28.02.2025 |
TER *** | 0.67% |
---|---|
TER date *** | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.66% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |